Company Oragenics Inc Nyse
Equities
US6840232036
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Products
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -71.37% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -71.37% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joseph Redmond
CEO | Chief Executive Officer | 64 | 12-27 |
Janet Huffman
DFI | Director of Finance/CFO | 52 | 06/03/23 |
Kimberly Murphy
BRD | Director/Board Member | 62 | 30/04/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Charles Pope
CHM | Chairman | 73 | 03/06/10 |
John Gandolfo
BRD | Director/Board Member | 63 | 03/10/23 |
Robert Koski
BRD | Director/Board Member | 65 | 29/06/09 |
Director/Board Member | 73 | 31/05/10 | |
Alan Dunton
BRD | Director/Board Member | 70 | 31/03/10 |
Bruce Cassidy
BRD | Director/Board Member | 74 | 03/10/23 |
Kimberly Murphy
BRD | Director/Board Member | 62 | 30/04/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 4,050,000 | 0 | 0 | 76.77 % |
Stock B | 1 | 4,480,693 | 3,439,769 ( 76.77 %) | 0 | |
Stock C | 0 | 5,417,000 | 0 | 0 |
Company contact information
Oragenics, Inc.
4902 Eisenhower boulevard Suite 125
33634-6310, Tampa
+813 286 7900
http://www.oragenics.comSector
1st Jan change | Capi. | |
---|---|---|
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.49% | 21.25B | |
-5.61% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+37.57% | 12.54B | |
-26.24% | 8.09B |